Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


William Strohl, Ph.D.

Owner and President at BiStro Biotech Consulting LLC


Dr. William Strohl is founder and owner of BiStro Biotech Consulting LLC, a consulting company started in 2016 to help biotechnology companies grow and expand their programs and capabilities.  Prior to retiring from Johnson & Johnson in August 2016, Dr. Strohl was VP and Head, Janssen BioTherapeutics, Janssen R&D, J&J, where he ran biologics discovery, early development, and technology development.  Prior to that, Dr. Strohl was head of Biologics Research, the discovery arm of Janssen BioTherapeutics, in which he led the significant improvement of both quantity and quality of development candidates.  Over his time at J&J, Dr. Strohl and his teams placed more than 30 highly innovative antibodies into development.  Before joining J&J, Dr. Strohl was at Merck and Co from 1997-2008, leading Natural Products Biology, initiating a Microbial Vaccines department, and then later, leading the Biologics discovery efforts, where he was involved in two biotechnology company acquisitions and multiple licenses to improve the discovery capabilities.  Prior to his work in industry, Dr. Strohl rose from Assistant to Full Professor in the Department of Microbiology and the Program of Biochemistry at The Ohio State University over the years 1980-1997.  Dr. Strohl has over 140 publications and 17 issued patents, has edited two books in the area of biotechnology, and has written a book entitled "Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area in the Pharma Industry", which was published in October, 2012.

Agenda Sessions